ArticleInternational journal of immunopathology and pharmacology

Corilagin relieves atherosclerosis via the toll-like receptor 4 signaling pathway in vascular smooth muscle cells.

Yujie Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.